NOOTROPIL

This brand name is authorized in Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, Hong Kong, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug NOOTROPIL contains one active pharmaceutical ingredient (API):

1 Piracetam UNII ZH516LNZ10 - PIRACETAM

Piracetam’s mode of action in cortical myoclonus is as yet unknown. Piracetam exerts its haemorrheological effects on the platelets, red blood cells, and vessel walls by increasing erythrocyte deformability and by decreasing platelet aggregation, erythrocyte adhesion to vessel walls and capillary vasospasm. Read about Piracetam

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NOOTROPIL Film-coated tablet / Oral solution / Solution for injection	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06BX03	Piracetam	N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BX Other psychostimulants and nootropics
Discover more medicines within N06BX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 576720090086917, 576720090087017
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 14325579
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 1416-MEE-0915, 2442-MEE-1116
Country: EE	Ravimiamet	Identifier(s): 1023343, 1074439, 1074440, 1813766, 1813777, 1813788, 1816444, 1826366, 1826377, 1826388, 1829347
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 54713, 55917
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 004861
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 143745, 162142, 381565, 38934, 40926, 94824
Country: HK	Department of Health Drug Office	Identifier(s): 24251, 36938
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1010980, 1010981, 1068160, 1079686, 1079687, 1081560, 1081561, 1081562, 1085195, 1085196, 1086183, 1087912, 1087913, 1090096, 1090113, 1090114, 1090115, 1090116, 1090117, 1090402, 1090403, 1092289
Country: MT	Medicines Authority	Identifier(s): MA030/00503
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 036M85, 89175
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 31186, 6548
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100048044, 100048050, 100048067, 100048073, 100088760, 100270995, 100299705, 100305216, 100306747, 100326460, 100326477, 100334710, 100339534, 100357621, 100361611, 100361657, 100385296, 100395159, 100420160, 100440300, 100450552, 100456300, 100456396, 100464994
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W57090001, W57090002, W57090003
Country: SG	Health Sciences Authority	Identifier(s): 00574P, 01279P, 08988P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699624090010, 8699624570031, 8699624750013
Country: ZA	Health Products Regulatory Authority	Identifier(s): F/1.1/184, J/1.1/399